COVID-19 and aging | sciencenewsnet.in

Breaking News

Expanding HPV vaccination to all adults aged 27-45 years unlikely to be cost-effective or efficient for HPV-related cancer prevention

Lack of control at work identified as cause for physician burnout and attrition

Alzheimer’s: A New Strategy to Prevent Neurodegeneration

Data Scientist Fixes His Sights on Speeding Up Drug Discovery

Pulmonary Medicine Updates Fall 2024

Healthcare to Research: The Many Ways Genetic Counselors Help Patients and Families

Expert Available on 2024 Holiday Travel: FAA Warns It May Need to Slow Air Traffic During Busy Travel Week

Nephrology Updates Fall 2024

Game-Changing Quantum Chemistry Calculations on Frontier Earn Gordon Bell Prize

Gordon Bell Climate Prize Goes to KAUST Frontier Users’ Exascale Climate Emulator

26 Nov, 2024

Severe COVID-19 caused by “senile” interferon response in older patients, researchers suggest

September 21, 2022 sarah JonasResearch Results

Researchers in Germany have discovered that age-dependent impairments in antiviral interferon proteins underlie the increased susceptibility of older patients to severe COVID-19. The study, published today in the Journal of Experimental Medicine (JEM), shows that aged mice infected with SARS-CoV-2 are protected from severe disease by treatment with one of these interferons, IFN-γ.